Comparison of the potential therapeutic effects of interleukin 2 or interleukin 4 secretion by a single tumour.

Engineering of a variety of rodent tumour cells to secrete either interleukin 2 (IL-2), or interleukin 4 (IL-4), has been demonstrated to reduce their tumorigenicity. However the mechanisms of action of secreted IL-2 and IL-4 have not been compared in a single rodent tumour. Here we demonstrate that...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, P. M., Flemming, C. L., Russell, S. J., McKay, I. A., MacLennan, K. A., Box, G. M., Eccles, S. A., Collins, M. K.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968575/
https://www.ncbi.nlm.nih.gov/pubmed/8347485

Ejemplares similares

Ejemplares similares